Objectivity Squared’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$645K Buy
2,539
+11
+0.4% +$2.56K 0.36% 29
2026
Q1
$618K Sell
2,528
-99
-4% -$23.1K 0.39% 28
2025
Q4
$544K Buy
2,627
+38
+1% +$7.51K 0.3% 33
2025
Q3
$480K Sell
2,589
-80
-3% -$13.7K 0.29% 35
2025
Q2
$408K Buy
2,669
+16
+0.6% +$2.46K 0.28% 35
2025
Q1
$403K Buy
2,653
+14
+0.5% +$2.19K 0.34% 27
2024
Q4
$375K Buy
2,639
+15
+0.6% +$2.32K 0.26% 35
2024
Q3
$419K Buy
2,624
+13
+0.5% +$2.07K 0.29% 31
2024
Q2
$394K Buy
2,611
+15
+0.6% +$2.23K 0.3% 32
2024
Q1
$390K Buy
2,596
+13
+0.5% +$2.07K 0.34% 31
2023
Q4
$405K Buy
+2,583
New +$396K 0.4% 27

Other funds holding JNJ

Objectivity Squared's JNJ Position: Q2 2026 in Review

Objectivity Squared increased its Johnson & Johnson (JNJ) stake by 0.44% in Q2 2026, buying an estimated $2.56K and bringing the position to 2,539 shares worth $645K. The position accounts for 0.36% of the portfolio, ranked #29.

Objectivity Squared first reported a position in JNJ in Q4 2023 and has held it in 11 quarters since. 4,677 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Objectivity Squared held 2,539 shares of Johnson & Johnson worth $645K as of Q2 2026.
  • Objectivity Squared bought 11 Johnson & Johnson shares in Q2 2026, an estimated $2.56K.
  • Johnson & Johnson made up 0.36% of Objectivity Squared's portfolio in Q2 2026, its #29 holding.
  • Objectivity Squared first reported a position in Johnson & Johnson in Q4 2023 and has held it in 11 quarters since.
  • 4,677 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Objectivity Squared's 13F filing for Q2 2026, filed 7 Aug 2026.